heor.tv
How was ISPOR founded?
heor.tv inteviewed Marilyn Dix Smith, Founding Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and asked How was ISPOR founded and how much has it changed over the years?
How is vision 2020 going to make an impact on patient healthcare?
heor.tv inteviewed Marilyn Dix Smith, Founding Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and asked about its impact on patient healthcare.
Observational Research in Health Technology Assessment
Duncan Dibble and Ruth Whittington speak to Jeff Trotter about observational research and its place in the changing health technology assessment (HTA) environment. heor.tv is a collaboration between http://www.healtheconomicsdigest.com and http://www.rxcomms.com
The Importance of Good Communications in Rational Decision Making
heor.tv interview Diana Brixner, former president of ISPOR and asked her how important good communications are with respect to rational decision making in the context of evidence supporting market access and reimbursement.
The changing landscape of the health technology assessment customer base
Duncan Dibble interviewed Judith Hargreaves, Associate Director for Global Health Economics and Outcomes Research at Ethicon Products about her approach to the customer base in light of the Health Technology Assessment (HTA) landscape.
Different Perspectives on Value Based Pricing in the UK
heor.tv polled Mark Sculpher and Ameet Bakhai with regards to what value based pricing means to them by providing some perspective on the subject.
Thoughts on the proposed UK Value Based Pricing System
As part of the heor.tv inteview with Jim Furniss, they asked about his thoughts on Value Based Pricing in the UK and what considerations should be mindful of before implementation in 2014.
Pricing and Reimbursement in Recession
heor.tv interviewed Jim Furniss, Director of Market Access at Bridgehead International and asked what effect the global recession has had on pricing, reimbursement and market access.
Pricing and Reimbursement Challenges in the Netherlands
heor.tv ask Marjolein Pompen what the current pricing and reimbursement activities she is doing now as opposed to previously in order to keep drugs in the Dutch market.
ISPOR Efforts in Communication
heor.tv interviewed Mark Sculpher, ISPOR president and asked; One of ISPORs Vision 2020 key goals is communication, Can you expand on what you want to improve about communication in this field?
- Twitter feed loading...
